Contact Us

Press Release

Syner-G BioPharma Group Named A BioSpace 2024 Best Places to Work Winner

November 8, 2023, Boston, MA Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, announced today that it has been named a BioSpace 2024 Best Place to Work. “I…

Read Full Article

Kristin Murray Joins Syner-G BioPharma Group as Senior Vice President of Regulatory Services

Murray to Spearhead Newly Integrated Department October 26, 2023, Boston, MA —Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, announced the addition of Kristin Murray as senior vice…

Read Full Article

Syner-G Biopharma Group Announces Neil Butera as New Chief Commercial Officer

Bringing Depth and Breadth of Biotech Experience to Oversee Continued Growth BOSTON (PRWEB) APRIL 06, 2023 – Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, today announced the…

Read Full Article

Syner-G BioPharma Group Acquires RMC Pharmaceutical Solutions

Expands Expertise in Biologics and Builds Scale in CMC and Quality Consulting Boston, MA, January 19, 2023 – Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, today announced…

Read Full Article

Syner-G Biopharma Group Announces Karen Casey as Chief People Officer

Rapid Growth Drives the Need for an Investment in Talent   January 10, 2023, Boston, MA — Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to the pharmaceutical and medical device industries, today…

Read Full Article

Syner-G Biopharma Group Appoints Ron Kraus as CEO

RESEARCH TRIANGLE PARK, NC: 13 June 2022 Syner-G BioPharma Group (“Syner-G”), a leading provider of consulting services to pharmaceutical and biotechnology clients, today announced that Ron Kraus has joined the company as Chief Executive Officer (CEO).

Read Full Article